Literature DB >> 26436530

Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation.

Ben J E Raveney1, Shinji Oki1, Hirohiko Hohjoh2, Masakazu Nakamura1,3, Wakiro Sato1,3, Miho Murata4, Takashi Yamamura1,3.   

Abstract

Development of acute experimental autoimmune encephalomyelitis (EAE) depends on Th17 cells expressing the nuclear factor NR4A2. However, in mice lacking NR4A2 in T cells, a late-onset disease is still inducible, despite a great reduction in acute inflammation. We here reveal that development of this late onset disease depends on cytotoxic T-cell-like CD4(+) T cells expressing the T-box transcription factor Eomesodermin (Eomes). T-cell-specific deletion of the Eomes gene remarkably ameliorates the late-onset EAE. Strikingly, similar Eomes(+) CD4(+) T cells are increased in the peripheral blood and cerebrospinal fluid from patients in a progressive state of multiple sclerosis. Collective data indicate an involvement of granzyme B and protease-activated receptor-1 in the neuroinflammation mediated by Eomes(+) CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26436530      PMCID: PMC4600741          DOI: 10.1038/ncomms9437

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  50 in total

Review 1.  Mechanisms regulating regional localization of inflammation during CNS autoimmunity.

Authors:  Emily Pierson; Sarah B Simmons; Luca Castelli; Joan M Goverman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

Authors:  Ralf Gold; Christopher Linington; Hans Lassmann
Journal:  Brain       Date:  2006-04-21       Impact factor: 13.501

3.  Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines.

Authors:  Yoshimitsu Doi; Shinji Oki; Tomoko Ozawa; Hirohiko Hohjoh; Sachiko Miyake; Takashi Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

4.  Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin.

Authors:  Kenji Ichiyama; Takashi Sekiya; Naoko Inoue; Taiga Tamiya; Ikko Kashiwagi; Akihiro Kimura; Rimpei Morita; Go Muto; Takashi Shichita; Reiko Takahashi; Akihiko Yoshimura
Journal:  Immunity       Date:  2011-05-19       Impact factor: 31.745

5.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

6.  Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis.

Authors:  Jun-ichi Satoh; Megumi Nakanishi; Fumiko Koike; Sachiko Miyake; Toshiyuki Yamamoto; Mitsuru Kawai; Seiji Kikuchi; Kyouichi Nomura; Kazumasa Yokoyama; Kohei Ota; Takashi Kanda; Toshiyuki Fukazawa; Takashi Yamamura
Journal:  Neurobiol Dis       Date:  2005-04       Impact factor: 5.996

Review 7.  CD4 CTL: living up to the challenge.

Authors:  Hilde Cheroutre; Mohammad Mushtaq Husain
Journal:  Semin Immunol       Date:  2013-11-15       Impact factor: 11.130

8.  Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling.

Authors:  Ben J E Raveney; Shinji Oki; Takashi Yamamura
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 9.  Cytotoxic CD4 T cells in antiviral immunity.

Authors:  Nikki B Marshall; Susan L Swain
Journal:  J Biomed Biotechnol       Date:  2011-11-22

10.  Granzyme B-induced neurotoxicity is mediated via activation of PAR-1 receptor and Kv1.3 channel.

Authors:  Tongguang Wang; Myoung-Hwa Lee; Elliot Choi; Carlos A Pardo-Villamizar; Sung Bin Lee; In Hong Yang; Peter A Calabresi; Avindra Nath
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

View more
  35 in total

1.  Eomesodermin promotes the development of type 1 regulatory T (TR1) cells.

Authors:  Ping Zhang; Jason S Lee; Kate H Gartlan; Iona S Schuster; Iain Comerford; Antiopi Varelias; Md Ashik Ullah; Slavica Vuckovic; Motoko Koyama; Rachel D Kuns; Kelly R Locke; Kirrilee J Beckett; Stuart D Olver; Luke D Samson; Marcela Montes de Oca; Fabian de Labastida Rivera; Andrew D Clouston; Gabrielle T Belz; Bruce R Blazar; Kelli P MacDonald; Shaun R McColl; Ranjeny Thomas; Christian R Engwerda; Mariapia A Degli-Esposti; Axel Kallies; Siok-Keen Tey; Geoffrey R Hill
Journal:  Sci Immunol       Date:  2017-04-07

2.  cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjögren's syndrome.

Authors:  H Takahashi; H Tsuboi; H Asashima; T Hirota; Y Kondo; M Moriyama; I Matsumoto; S Nakamura; T Sumida
Journal:  Clin Exp Immunol       Date:  2017-07-21       Impact factor: 4.330

3.  Three immune-mediated disease models induced by Theiler's virus: Multiple sclerosis, seizures and myocarditis.

Authors:  Ikuo Tsunoda; Fumitaka Sato; Seiichi Omura; Mitsugu Fujita; Namie Sakiyama; Ah-Mee Park
Journal:  Clin Exp Neuroimmunol       Date:  2016-10-25

4.  Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.

Authors:  Caroline Stienne; Michaël F Michieletto; Mehdi Benamar; Nadège Carrié; Isabelle Bernard; Xuan-Hung Nguyen; Yannick Lippi; Fanny Duguet; Roland S Liblau; Stephen M Hedrick; Abdelhadi Saoudi; Anne S Dejean
Journal:  Immunity       Date:  2016-10-11       Impact factor: 31.745

5.  Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells.

Authors:  Ana Raykova; Paolo Carrega; Frank M Lehmann; Robert Ivanek; Vanessa Landtwing; Isaak Quast; Jan D Lünemann; Daniela Finke; Guido Ferlazzo; Obinna Chijioke; Christian Münz
Journal:  Blood Adv       Date:  2017-12-14

6.  Brain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective.

Authors:  Hideaki Nishihara; Britta Engelhardt
Journal:  Handb Exp Pharmacol       Date:  2022

7.  Cytotoxicity-Related Gene Expression and Chromatin Accessibility Define a Subset of CD4+ T Cells That Mark Progression to Type 1 Diabetes.

Authors:  Naiara G Bediaga; Alexandra L Garnham; Gaetano Naselli; Esther Bandala-Sanchez; Natalie L Stone; Joanna Cobb; Jessica E Harbison; John M Wentworth; Annette-G Ziegler; Jennifer J Couper; Gordon K Smyth; Leonard C Harrison
Journal:  Diabetes       Date:  2022-03-01       Impact factor: 9.461

8.  Single-cell landscape of immunological responses in patients with COVID-19.

Authors:  Ji-Yuan Zhang; Xiang-Ming Wang; Xudong Xing; Zhe Xu; Chao Zhang; Jin-Wen Song; Xing Fan; Peng Xia; Jun-Liang Fu; Si-Yu Wang; Ruo-Nan Xu; Xiao-Peng Dai; Lei Shi; Lei Huang; Tian-Jun Jiang; Ming Shi; Yuxia Zhang; Alimuddin Zumla; Markus Maeurer; Fan Bai; Fu-Sheng Wang
Journal:  Nat Immunol       Date:  2020-08-12       Impact factor: 25.606

9.  Involvement of cytotoxic Eomes-expressing CD4+ T cells in secondary progressive multiple sclerosis.

Authors:  Ben J E Raveney; Wakiro Sato; Daiki Takewaki; Chenyang Zhang; Tomomi Kanazawa; Youwei Lin; Tomoko Okamoto; Manabu Araki; Yukio Kimura; Noriko Sato; Terunori Sano; Yuko Saito; Shinji Oki; Takashi Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

10.  Bona Fide Th17 Cells without Th1 Functional Plasticity Protect against Influenza.

Authors:  Kunal Dhume; Caroline M Finn; Priyadharshini Devarajan; Ayushi Singh; Joanne D Tejero; Emily Prokop; Tara M Strutt; Stewart Sell; Susan L Swain; Karl Kai McKinstry
Journal:  J Immunol       Date:  2022-03-25       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.